Forbes May 30, 2019
Tempus, a health technology startup based in Chicago, raised $200 million in new funding at a $3.1 billion valuation, the company announced on Thursday. Tempus was launched in 2015 by Groupon cofounder Eric Lefkofsky. To date the business has raised $520 million over six funding rounds.
Investors in the latest round include New Enterprise Associates, Novo Holdings, Revolution Growth—chaired by AOL cofounder Steve Case—and funds and accounts managed by T. Rowe Price. Lefkofsky also participated; he has put more than $100 million of his own money into the business.
At its core, Tempus is a data company. It gathers and analyzes clinical and molecular data, mainly related to cancer treatment, and is creating a library of that information it hopes...
Today's Sponsors
Today's Sponsor